Fierce Drug Dev Forum 2019 has ended
Back To Schedule
Monday, October 28 • 4:45pm - 5:30pm
Case Study: Living with the Deal - Managing the Legend Biotech and Janssen Global CAR-T Collaboration

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Overview of the transaction from each company’s perspective
  • How the companies align objectives and navigate pharma/biotech differences
  • The importance of proactive alliance management

avatar for Meeta Chatterjee, Ph.D.

Meeta Chatterjee, Ph.D.

Senior Vice President, Global Business Development, LEGEND BIOTECH
Meeta Chatterjee is SVP, Global Business Development for Legend Biotech. Legend Biotech is focused on CAR-T and Cell Therapies for oncology and infectious diseases. Meeta currently provides oversight for all business development activities including prioritizing opportunities, managing... Read More →
avatar for Debi Watson

Debi Watson

Vice President, Business Development, Oncology, JANSSEN BUSINESS DEVELOPMENT
Debi Watson is the head of the Oncology Business Development Group at Johnson & Johnson Innovation, Janssen Business Development, a position she has held since May 2013.  In this role she leads Business Development Strategy in coordination with Oncology R&D and Commercial leadership... Read More →

Monday October 28, 2019 4:45pm - 5:30pm PDT